Huahong花红品牌怎么样 申请店铺

我要投票 Huahong花红在女性洗液行业中的票数:639 更新时间:2026-01-14
Huahong花红是哪个国家的品牌?「Huahong花红」是 广西壮族自治区花红药业股份有限公司 旗下著名品牌。该品牌发源于广西,由创始人韦飞燕在1982期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力Huahong花红品牌出海!将品牌入驻外推网,定制Huahong花红品牌推广信息,可以显著提高Huahong花红产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

Huahong花红怎么样

广西花红药业股份有限公司集药材基地、科研、生产、销售为一体,是国家重点中成药企业,始建于20世纪70年代初。2002年完成国有改制,与上海复星医药(集团)股份有限公司进行合资合作,充分运用复星医药的资金、技术、管理等综合资源,在现代中药、药材种植、医药流通、资本运营等领域实现共赢;2005年花红品牌向健康产业延伸,建立子公司花红俱乐部。

花红药业拥有“花红”驰名保护和40多项国家专利,改制后投入巨资改造现代中药的软硬件设施,通过了GMP、CGMP,达到国际注册标准,是广西区技术中心、国家级高新技术企业。

花红药业GMP生产基地占地200亩、年生产能力达10亿元以上,生产能力规模居广西中成药行业首位。公司拥有以妇科产品为主的中成药50多个品种,包括国家中药保护品种花红片、花红颗粒、葛根芩连丸、消肿止痛酊,以及花红随身洁、养血当归糖浆等。其中独家品种花红片、花红颗粒、花红胶囊、消肿止痛酊、葛根芩连丸、解毒生肌膏入选国家《药品目录(2009年版)》。治疗流感、腹泻的独家产品葛根芩连丸是全国中医院急诊必备用药,由于具有抗病毒、起效快特点,多次在国家发生大的疫情时,被国家卫生部推荐为诊疗用药。主导产品花红片、消肿止痛酊是全国治疗妇科炎症用药和外用镇痛酊剂类用药的知名品牌。

花红药业奉行“关心健康,爱护家庭”的宗旨,秉承“坦诚、开放、严谨、感恩”的企业理念,致力于女性健康事业,为改善和提高女性健康水平,提供专业化的优质药品和服务,发展以品牌为核心的妇科产品群,努力成为中国乃至全球女性用药的一流企业和女性健康专家。

Guangxi Huahong Pharmaceutical Co., Ltd. is a national key Chinese patent medicine enterprise, which integrates the base of medicinal materials, scientific research, production and sales. It was founded in the early 1970s. In 2002, the state-owned restructuring was completed, and a joint venture cooperation was carried out with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. to make full use of Fosun Pharmaceutical's capital, technology, management and other comprehensive resources to achieve a win-win situation in the fields of modern Chinese medicine, herbal medicine planting, pharmaceutical circulation, capital operation, etc.; in 2005, Huahong brand extended to the health industry and established a subsidiary Huahong club. Huahong Pharmaceutical Co., Ltd. is well-known for its "Huahong" protection and more than 40 national patents. After the reform, it invested heavily in the reconstruction of the software and hardware facilities of modern Chinese medicine, passed GMP and cGMP, and reached the international registration standard. It is a technology center of Guangxi district and a national high-tech enterprise. Huahong pharmaceutical GMP production base covers an area of 200 mu, with an annual production capacity of more than 1 billion yuan, ranking first in Guangxi's proprietary Chinese medicine industry. The company has more than 50 kinds of traditional Chinese medicine mainly for gynecology products, including Huahong tablet, Huahong granule, Gegen Qinlian pill, Xiaozhong Zhitong tincture, Huahong portable cleaning, blood nourishing Angelica syrup, etc. Among them, the exclusive varieties of Huahong tablet, Huahong granule, Huahong capsule, Xiaozhongzhitong tincture, Gegenqinlian pill and Jiedu Shengji ointment were selected into the National Drug Catalogue (2009 Edition). Gegen Qinlian pill, an exclusive product for the treatment of influenza and diarrhea, is an essential medicine for emergency treatment in Chinese medicine hospitals. Because of its antiviral and quick effect, it has been recommended by the Ministry of health as a medicine for diagnosis and treatment when there are many large epidemics in the country. Huahong tablet and Xiaozhongzhitong tincture, the leading products, are well-known brands for the treatment of gynecological inflammation and external analgesic tincture. Huahong pharmaceutical adheres to the tenet of "caring for health, caring for family", adheres to the enterprise concept of "honesty, openness, preciseness and gratitude", devotes itself to the cause of women's health, provides professional high-quality drugs and services for improving and improving women's health level, develops the gynaecological product group with brand as the core, and strives to become the first-class enterprise and women's medicine in China and even in the world Health experts.

本文链接: https://brand.waitui.com/f7cc93a62.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

霍尼韦尔:旗下量子计算公司Quantinuum计划在美提交IPO申请

霍尼韦尔宣布,其控股子公司Quantinuum计划向美国证券交易委员会提交一份草案,涉及Quantinuum普通股拟议的首次公开发行事宜。本次拟发行股份数量及价格区间尚未确定。该发行计划需视市场及其他条件而定,并须待美国证券交易委员会完成审查程序后方可实施。(界面)

58分钟前

苏州固锝:定增申请获深交所审核通过

36氪获悉,苏州固锝公告,公司于2026年1月14日收到深交所出具的《关于苏州固锝电子股份有限公司申请向特定对象发行股票的审核中心意见告知函》,深交所发行上市审核机构对公司向特定对象发行股票的申请文件进行了审核,认为公司符合发行条件、上市条件和信息披露要求。公司本次向特定对象发行股票事项尚需获得中国证监会同意注册后方可实施。

58分钟前

美股大型科技股盘前多数下跌,奈飞涨超1%

36氪获悉,美股大型科技股盘前多数下跌,截至发稿,Meta跌0.69%,亚马逊跌0.66%,英伟达跌0.65%,微软跌0.61%,Arm跌0.52%,特斯拉跌0.44%,苹果跌0.37%;奈飞涨超1%。

58分钟前

热门中概股美股盘前涨跌不一,B站涨超4%

36氪获悉,热门中概股美股盘前涨跌不一,截至发稿,B站涨超4%,阿里巴巴涨超3%,百度、爱奇艺涨近1%;网易、理想汽车跌超1%,京东跌近1%,小鹏汽车跌0.19%。

58分钟前

华人健康:股东赛富投资拟减持不超2%公司股份

36氪获悉,华人健康公告,股东苏州赛富、黄山赛富、腾元投资、长菁投资(合称“赛富投资”)合计持有公司5.03%股份,计划减持不超过800万股(占公司总股本的2%),减持原因为资金安排需要,减持方式为集中竞价交易和大宗交易,减持期间为公告披露之日起十五个交易日后的三个月内(即2026年2月5日至2026年4月30日)。

58分钟前

本页详细列出关于Huahong花红的品牌信息,含品牌所属公司介绍,Huahong花红所处行业的品牌地位及优势。
咨询